What to see when you are looking at confusion: A review of the neuroimaging of acute encephalopathy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 4, 2015, Pages 446-459

  Sutter, Raoul ^a,b,c   Kaplan, Peter W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE BRAIN DISEASE; ACUTE DISSEMINATED ENCEPHALOMYELITIS; BRAIN BLOOD FLOW; BRAIN TOXICITY; CENTRAL PONTINE MYELINOLYSIS; CONFUSION; CONTRAST ENHANCEMENT; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEPATIC ENCEPHALOPATHY; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HYPERAMMONEMIA ENCEPHALOPATHY; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUSAC SYNDROME; UREMIC ENCEPHALOPATHY; WERNICKE ENCEPHALOPATHY; BRAIN DISEASES; PATHOLOGY; PROCEDURES; PSYCHOLOGY;

BRAIN DISEASES; CONFUSION; HUMANS; NEUROIMAGING;

EID: 84925374415     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308216     Document Type: Review

References (90)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Task Force on DSM-IV, editor. American Psychiatric Publication, 2000.
2. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-76.
3. Kaplan PW, Rossetti AO. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. J Clin Neurophysiol 2011;28:233-51.
4. Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 2008;28:417-39; quiz 617.
5. Bathla G, Hegde AN. MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults. Clin Radiol 2013;68:545-54.
6. Arbelaez A, Castillo M, Mukherji SK. Diffusion-weighted MR imaging of global cerebral anoxia. AJNR Am J Neuroradiol 1999;20:999-1007.
7. Wijman CA, Mlynash M, Caulfield AF, et al. Prognostic value of brain diffusion-weighted imaging after cardiac arrest. Ann Neurol 2009;65:394-402.
8. Wijdicks EF, Campeau NG, Miller GM. MR imaging in comatose survivors of cardiac resuscitation. AJNR Am J Neuroradiol 2001;22:1561-5.
9. Stevens RD, Sutter R. Prognosis in severe brain injury. Crit Care Med 2013;41:1104-23.
10. Fugate JE, Wijdicks EF, Mandrekar J, et al. Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol 2010;68:907-14.
11. Choi SP, Park KN, Park HK, et al. Diffusion-weighted magnetic resonance imaging for predicting the clinical outcome of comatose survivors after cardiac arrest: a cohort study. Crit Care 2010;14:R17.
12. Cronberg T, Rundgren M, Westhall E, et al. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology 2011;77:623-30.
13. Kreis R, Arcinue E, Ernst T, et al. Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 1996;97:1142-54.
14. Sharshar T, Annane D, de la Grandmaison GL, et al. The neuropathology of septic shock. Brain Pathol 2004;14:21-33.
15. Piazza O, Cotena S, De Robertis E, et al. Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement. Neurochem Res 2009;34:1289-92.
16. Sharshar T, Carlier R, Bernard F, et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med 2007;33:798-806.
17. Park JH, Kim HJ, Kim SM. Acute chorea with bilateral basal ganglia lesions in diabetic uremia. Can J Neurol Sci 2007;34:248-50.
18. Wang HC, Brown P, Lees AJ. Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord 1998;13:952-7.
19. Kang E, Jeon SJ, Choi SS. Uremic encephalopathy with atypical magnetic resonance features on diffusion-weighted images. Korean J Radiol 2012;13:808-11.
20. Sheu YL, Cheng SJ, Chen YM, et al. The syndrome of bilateral basal ganglia lesions in diabetic uremic patients presenting with a relapsing and remitting course: a case report. Acta Neurol Taiwan 2007;16:226-30.
21. Dicuonzo F, Di Fede R, Salvati A, et al. Acute extrapyramidal disorder with bilateral reversible basal ganglia lesions in a diabetic uremic patient: diffusion-weighted imaging and spectroscopy findings. J Neurol Sci 2010;293:119-21.
22. Wang HC, Hsu JL, Shen YY. Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study. Clin Nucl Med 2004;29:475-8.
23. Rimar D, Bitterman H. Hyperammonemic coma: beyond hepatic encephalopathy. South Med J 2008;101:467-8.
24. Takanashi J, Barkovich AJ, Cheng SF, et al. Brain MR imaging in acute hyperammonemic encephalopathy arising from late-onset ornithine transcarbamylase deficiency. AJNR Am J Neuroradiol 2003;24:390-3.
25. Rovira A, Alonso J, Cordoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 2008;29:1612-21.
26. Nomiyama K, Tsuji H, Ikeda K, et al. [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis]. Fukuoka Igaku Zasshi 1991;82:521-7.
27. McKinney AM, Lohman BD, Sarikaya B, et al. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol 2010;31:1471-9.
28. Kohira I, Matsuo E, Shiro Y, et al. Hepatic encephalopathy with increased cerebral blood flow in SPECT and MRI abnormalities in the basal ganglia. Jpn J Psychiatry Neurol 1994;48:33-6.
29. Weissenborn K, Berding G, Kostler H. Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 2000;15:173-8.
30. Nakagawa Y, Matsumura K, Iwasa M, et al. Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy. Ann Nucl Med 2004;18:123-9.
31. Fujioka M, Okuchi K, Hiramatsu KI, et al. Specific changes in human brain after hypoglycemic injury. Stroke 1997;28:584-7.
32. Lim CC, Gan R, Chan CL, et al. Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings. Radiology 2009;250:193-201.
33. Ma JH, Kim YJ, Yoo WJ, et al. MR imaging of hypoglycemic encephalopathy: lesion distribution and prognosis prediction by diffusion-weighted imaging. Neuroradiology 2009;51:641-9.
34. Lai PH, Tien RD, Chang MH, et al. Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR Am J Neuroradiol 1996;17:1057-64.
35. Strange K, Jackson PS. Swelling-activated organic osmolyte efflux: a new role for anion channels. Kidney Int 1995;48:994-1003.
36. Menger H, Jorg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 1999;246:700-5.
37. Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol 2004;25:210-13.
38. Graff-Radford J, Fugate JE, Kaufmann TJ, et al. Clinical and radiologic correlations of central pontine myelinolysis syndrome. Mayo Clin Proc 2011;86:1063-7.
39. Kim JS, Lee KS, Han SR, et al. Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis. Mov Disord 2003;18:342-5.
40. Zuccoli G, Gallucci M, Capellades J, et al. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol 2007;28:1328-31.
41. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971;7:1-206.
42. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998;171:1131-7.
43. Gallucci M, Bozzao A, Splendiani A, et al. Wernicke encephalopathy: MR findings in five patients. AJNR Am J Neuroradiol 1990;11:887-92.
44. Park SH, Kim M, Na DL, et al. Magnetic resonance reflects the pathological evolution of Wernicke encephalopathy. J Neuroimaging 2001;11:406-11.
45. Murata T, Fujito T, Kimura H, et al. Serial MRI and (1)H-MRS of Wernicke's encephalopathy: report of a case with remarkable cerebellar lesions on MRI. Psychiatry Res 2001;108:49-55.
46. Fei GQ, Zhong C, Jin L, et al. Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy. AJNR Am J Neuroradiol 2008;29:164-9.
47. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
48. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043-9.
49. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-12.
50. Eichler FS, Wang P, Wityk RJ, et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002;23:833-7.
51. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-48.
52. Rahmlow MR, Kantarci O. Fulminant demyelinating diseases. Neurohospitalist 2013;3:81-91.
53. Caldemeyer KS, Smith RR, Harris TM, et al. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994;36:216-20.
54. Campi A, Filippi M, Comi G, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. AJNR Am J Neuroradiol 1995;16:115-23.
55. Balasubramanya KS, Kovoor JM, Jayakumar PN, et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 2007;49:177-83.
56. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8.
57. Duffey P, Yee S, Reid IN, et al. Hashimoto's encephalopathy: postmortem findings after fatal status epilepticus. Neurology 2003;61:1124-6.
58. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(Pt 7):1481-94.
59. Lawn ND, Westmoreland BF, Kiely MJ, et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 2003;78:1363-8.
60. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 2008;10:131-7.
61. Yoneda M. [Diagnosis and treatments of Hashimoto's encephalopathy]. Rinsho Shinkeigaku 2012;52:1240-2.
62. Mahad DJ, Staugaitis S, Ruggieri P, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci 2005;228:3-5.
63. Su TH, Jin EH, He W. Hashimoto encephalopathy: a case report with proton MR spectroscopic findings. Chin Med J (Engl) 2011;124:3420-2.
64. Zhao W, Li J, Wang J, et al. A case of Hashimoto encephalopathy: clinical manifestation, imaging, pathology, treatment, and prognosis. Neurologist 2011;17:141-3.
65. Hsu CS, Wu YC, Lu MK, et al. 99mTc ECD and 99mTc TRODAT-1 SPECT in Hashimoto encephalopathy. Clin Nucl Med 2012;37:e86-8.
66. Fuertes J, Garcia-Burillo A, Castell-Conesa J, et al. Functional neuroimaging in Hashimoto's encephalitis: a physiopathological imaging? Eur J Nucl Med Mol Imaging 2009;36:726.
67. Aurelius E, Johansson B, Skoldenberg B, et al. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol 1993;39:179-86.
68. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006;314:308-12.
69. Sili U, Kaya A, Mert A, et al. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 2014;60:112-18.
70. Baringer JR. Herpes simplex infections of the nervous system. Neurol Clin 2008;26:657-74, viii.
71. Hasegawa Y, Morishita M, Ikeda T, et al. Early diagnosis of herpes simplex virus encephalitis by single photon emission computed tomography (SPECT) in patients with normal MRI. Rinsho Shinkeigaku 1996;36:475-80.
72. Riancho J, Delgado-Alvarado M, Sedano MJ, et al. Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience. Neurol Sci 2013;34:1879-81.
73. Taira N, Kamei S, Morita A, et al. Predictors of a prolonged clinical course in adult patients with herpes simplex virus encephalitis. Intern Med 2009;48:89-94.
74. Mekan SF, Wasay M, Khelaeni B, et al. Herpes simplex encephalitis: analysis of 68 cases from a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 2005;55:146-8.
75. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979;29:313-16.
76. Allmendinger AM, Spektor V, Destian S. CT and MR imaging of Susac syndrome in a young male presenting with acute disorientation. Clin Imaging 2010;34:138-42.
77. Gross M, Eliashar R. Update on Susac's syndrome. Curr Opin Neurol 2005;18:311-14.
78. White ML, Zhang Y, Smoker WR. Evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values. AJNR Am J Neuroradiol 2004;25:706-13.
79. Dielman C, Laureys G, Meurs A, et al. Susac syndrome: a case report and PET imaging findings. Acta Neurol Belg 2009;109:226-30.
80. Puoti G, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012;11:618-28.
81. Hayashi R, Hanyu N, Kuwabara T, et al. Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease. Acta Neurol Scand 1992;85:161-5.
82. Schroter A, Zerr I, Henkel K, et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-7.
83. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-9.
84. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 2011;76:1711-19.
85. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129(Pt 9):2278-87.
86. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003;24:1560-9.
87. Yi SH, Park KC, Yoon SS, et al. Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob disease. Neurol Sci 2008;29:251-5.
88. Srivastava T, Kadam N. Bilateral putaminal hemorrhagic necrosis with rapid recovery of sensorium in a patient with methanol intoxication. J Postgrad Med 2013;59:243-4.
89. Ari S, Caca I, Kayabasi H. Bilateral complete optic atrophy and hemorrhagic infarction of the putamen caused by methanol intoxication. Ann Ophthalmol (Skokie) 2007;39:249-52.
90. Caparros-Lefebvre D, Policard J, Sengler C, et al. Bipallidal haemorrhage after ethylene glycol intoxication. Neuroradiology 2005;47:105-7.